Answers are grounded in this paper and cite their sources.
This study examines the relationship between corporate social responsibility (CSR) and pharmaceutical innovation performance, with a focus on the role of the innovation ecosystem in mediating this relationship. The study highlights the importance of balancing the economic and social aspects of pharmaceutical enterprises to promote their innovative development while fulfilling social responsibilities. Using a systematic review of relevant literature, the study constructs a relationship model between CSR, innovation ecosystem support, and pharmaceutical innovation performance. The study collects measurement items, develops measurement scales, and conducts a large-scale formal survey to verify the research hypotheses. Regression analysis is used to explore the reasons for the establishment and non-establishment of the hypotheses. The paper summarizes the research work and proposes management suggestions. The study contributes to the growing research on CSR and performance by providing a thorough understanding of how CSR affects corporate performance in the context of pharmaceutical enterprises.
No takes yet. Share an insight, caveat, or question.
Huang Lu (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: